REMS

| Article

PRNewswire: Today, as part of the U.S. Food and Drug Administration's ongoing efforts to address the coronavirus pandemic (COVID-19), the agency issued a new guidance to sponsors and healthcare providers regarding certain Risk Evaluation and Mitigation Strategy (REMS)-required testing during this...

Subscribe to REMS

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.